文献速递肿瘤 PET/CT骨显像与常规 SPECT

68Ga CXCR-4 PET/CT 诊断模拟肾细胞癌的非典型髓外浆细胞瘤一例

68Ga CXCR-4 PET/CT Imaging in an Atypical Case of Extramedullary Plasmacytoma Mimicking as Renal Cell Carcinoma.
PubMed 文献 · Clin Nucl Med · 2019-01-01

本文报道一例疑似肾细胞癌的浆细胞瘤患者,68Ga CXCR-4 PET/CT 显示左肾周区域示踪剂高摄取病灶,PET/CT 引导活检证实为浆细胞瘤。该案例表明 68Ga CXCR-4 PET/CT 及引导活检有助于精确定位病灶并指导明确治疗。

要点

  • 68Ga CXCR-4 PET/CT 可显示浆细胞瘤的示踪剂高摄取病灶。
  • PET/CT 引导活检可证实浆细胞瘤诊断。
  • 该显像有助于精确定位病灶并指导治疗决策。

核心结论

  • 68Ga CXCR-4 PET/CT 显像及引导活检有助于精确定位浆细胞瘤病灶并帮助明确患者管理。

研究设计与样本

  • 单例病例报告。

主要发现

  • 68Ga CXCR-4 PET/CT 显示左肾周区域示踪剂高摄取病灶。
  • PET/CT 引导活检证实为浆细胞瘤。

临床怎么用

  • 对于疑似肾细胞癌但不典型的浆细胞瘤病例,可考虑使用 68Ga CXCR-4 PET/CT 定位病灶并引导活检。

局限性

  • 本文为单例病例报告,未提供诊断性能或疗效的系统性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple-myeloma (MM) is a malignant plasma cell proliferation disorder and the second most common blood malignancy after non-Hodgkin lymphoma. The chemokine (CXCR-4) receptor analogues are the newer agents being postulated for myeloma imaging and have shown good diagnostic performance. We report a case of plasmacytoma with suspicious renal cell carcinoma, in whom Ga CXCR-4 PET/CT revealed tracer-avid lesion in the left perinephric region. PET/CT-guided biopsy from the tracer-avid lesion revealed plasmacytoma. PET/CT-imaging and guided biopsy using Ga CXCR4 receptor ligand, proved its usefulness for accurate localization of the culprit lesion and helped in definitive management of the patient.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kumar R, Mittal BR, Sood A, et al. 68Ga CXCR-4 PET/CT Imaging in an Atypical Case of Extramedullary Plasmacytoma Mimicking as Renal Cell Carcinoma. Clin Nucl Med. 2019. PMID: 30985424. doi:10.1097/RLU.0000000000002574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。